THE HISTOLOGY AND DEVELOPMENT OF HEPATIC NODULES AND CARCINOMA IN C3H/HE AND C57BL/6 MICE FOLLOWING CHRONIC PHENOBARBITONE ADMINISTRATION

被引:26
作者
EVANS, JG [1 ]
COLLINS, MA [1 ]
LAKE, BG [1 ]
BUTLER, WH [1 ]
机构
[1] BIBRA TOXICOL INT,WOODMANSTERNE RD,CARSHALTON SM5 4DS,SURREY,ENGLAND
关键词
BASOPHILIC NODULE; EOSINOPHILIC NODULE; METASTASIS; REVERSAL; MIXED FUNCTION OXIDASES;
D O I
10.1177/019262339202000405
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Male C3H/He and C57BL/6 mice were given diets containing sodium phenobarbitone (PB) to allow a daily intake of 85 mg/kg. Control and treated animals were killed at 5, 30, 40, 60, and 80 wk. Other mice were killed in extremis or at the end of the respective experiments: 91 wk for C3H/He and 100 wk for the C57BL/6 animals. A basophilic nodule was found in 115 control C3H/He mice at 30 wk; these nodules increased in number with time so that nodules of this type were found in approximately 70% of animals by 91 wk. Nodules were not found in control C57BL/6 mice until 80 wk, when they were found in 4% of mice. PB treatment markedly increased the number of hepatic nodules in both strains of mice. The additional nodule burden was due to the development of a second nodule type formed of large cells with a predominantly eosinophilic cytoplasm. C3H/He animals given PB for 60 wk and then returned to a control diet bore fewer nodules at 91 wk than treated mice killed at 60 or 91 wk. The cumulative incidence of carcinoma in control C3H/He and C57BL/6 mice was 28 and 4%, respectively. The incidence of carcinoma was not increased by PB treatment in either strain. It is concluded that both strains of mice behave in a qualitively similar way to PB administration, although they show considerable quantitative differences in terms of the time and number of nodules that develop. Furthermore, the increased nodule numbers associated with PB treatment were not accompanied by an increase in the number of carcinomas.
引用
收藏
页码:585 / 594
页数:10
相关论文
共 22 条
[1]  
Becker F.F., Morphological classification of mouse liver tumours based on biological characteristics, Cancer Res, 42, pp. 3918-3923, (1982)
[2]  
Becker F.F., Tumour phenotype and susceptibility to progression as an expression of subpopulations of initiated murine cells, Cancer Res, 45, pp. 768-773, (1985)
[3]  
Becker F.F., Progression of tumour histotype during mouse hepatocarcinogenesis associated with the viable yellow (Avy) gene, Cancer Res, 46, pp. 2241-2244, (1986)
[4]  
Becker F.F., Soute D.L., A constitutive deficiency in the monoxygenase system of spontaneous mouse liver tumours, Carcinogenesis, 5, pp. 785-788, (1984)
[5]  
Collins M.A., Studies on the induction of hepatic xenobiotic metabolising enzymes in rodents: Relevance to nodule formation, (1985)
[6]  
Collins M.A., Lake B.G., Evans J.G., Gangolli S.D., Conning D.M., Sustained induction of hepatic xenobiotic metabolising enzyme activities by phenobarbitone in C3H/He mice: Relevance to nodule formation, Toxicology, 33, pp. 129-144, (1984)
[7]  
Cunninghame M.E., Evans J.G., Butler W.H., An ultrastructural study of spontaneous and phenobarbitone induced nodules in the mouse liver, Int. J. Exp. Pathol, 72, pp. 695-703, (1991)
[8]  
Drinkwater N.R., Ginsler J.J., The histology and development of hepatic nodules in C57BL/6 mice following chronic administration of phenobarbitone, Carcinogenesis, 7, pp. 627-631, (1986)
[9]  
Evans J.G., Collins M.A., Savage S.A., Lake B.G., Butler W.H., The histology and development of hepatic nodules in C3H/He mice following chronic administration of phenobarbitone, Carcinogenesis, 7, pp. 627-631, (1986)
[10]  
Fox T.R., Schumann A.M., Watanabe P.G., Yano B.L., Maher V.M., McCormick J.J., Mutational analysis of H-ras oncogenes in spontaneous C57BL/6 x C3H/He mouse liver tumours and tumours induced with genotoxic and non-genotoxic hepatocarcinogens, Cancer Res, 50, pp. 4014-4019, (1990)